BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30573850)

  • 21. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.
    Kashima J; Yoshida M; Jimbo K; Izutsu K; Ushiku T; Yonemori K; Yoshida A
    Am J Surg Pathol; 2021 Mar; 45(3):347-355. PubMed ID: 32826530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK-positive histiocytosis with
    Gupta GK; Xi L; Pack SD; Jones JB; Pittaluga S; Raffeld M; Jaffe ES
    Haematologica; 2019 Nov; 104(11):e534-e536. PubMed ID: 31371408
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.
    Bridge JA; Sumegi J; Druta M; Bui MM; Henderson-Jackson E; Linos K; Baker M; Walko CM; Millis S; Brohl AS
    Mod Pathol; 2019 Nov; 32(11):1593-1604. PubMed ID: 31189996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
    Wolter NE; Ngan B; Whitlock JA; Dickson BC; Propst EJ
    Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109585. PubMed ID: 31351348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local ALK-Positive Histiocytosis With Unusual Morphology and Novel
    Tran TAN; Chang KTE; Kuick CH; Goh JY; Chang CC
    Int J Surg Pathol; 2021 Aug; 29(5):543-549. PubMed ID: 33243034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated ALK-positive histiocytosis with
    Qiu L; Weitzman SP; Nastoupil LJ; Williams MD; Medeiros LJ; Vega F
    Leuk Lymphoma; 2021 May; 62(5):1234-1238. PubMed ID: 33353436
    [No Abstract]   [Full Text] [Related]  

  • 27. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
    Durham BH; Lopez Rodrigo E; Picarsic J; Abramson D; Rotemberg V; De Munck S; Pannecoucke E; Lu SX; Pastore A; Yoshimi A; Mandelker D; Ceyhan-Birsoy O; Ulaner GA; Walsh M; Yabe M; Petrova-Drus K; Arcila ME; Ladanyi M; Solit DB; Berger MF; Hyman DM; Lacouture ME; Erickson C; Saganty R; Ki M; Dunkel IJ; Santa-María López V; Mora J; Haroche J; Emile JF; Decaux O; Geissmann F; Savvides SN; Drilon A; Diamond EL; Abdel-Wahab O
    Nat Med; 2019 Dec; 25(12):1839-1842. PubMed ID: 31768065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK-Positive Histiocytosis with Peripheral Blood Histiocytes: A Case Report.
    Swain F; Williams B; Barbaro P
    Acta Haematol; 2021; 144(2):218-221. PubMed ID: 32721959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M
    Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. StALKing Histiocytosis: ALK-Positive Histiocytosis Identified through Peripheral Blood Smear.
    Andolina JR
    Acta Haematol; 2021; 144(3):241-243. PubMed ID: 32980847
    [No Abstract]   [Full Text] [Related]  

  • 31. ALK-Positive Histiocytosis: A Case Report and Literature Review.
    Jaber OI; Jarrah DA; Hiasat M; Hussaini MA
    Turk Patoloji Derg; 2021; 37(2):172-177. PubMed ID: 33973641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.
    Kemps PG; Picarsic J; Durham BH; Hélias-Rodzewicz Z; Hiemcke-Jiwa L; van den Bos C; van de Wetering MD; van Noesel CJM; van Laar JAM; Verdijk RM; Flucke UE; Hogendoorn PCW; Woei-A-Jin FJSH; Sciot R; Beilken A; Feuerhake F; Ebinger M; Möhle R; Fend F; Bornemann A; Wiegering V; Ernestus K; Méry T; Gryniewicz-Kwiatkowska O; Dembowska-Baginska B; Evseev DA; Potapenko V; Baykov VV; Gaspari S; Rossi S; Gessi M; Tamburrini G; Héritier S; Donadieu J; Bonneau-Lagacherie J; Lamaison C; Farnault L; Fraitag S; Jullié ML; Haroche J; Collin M; Allotey J; Madni M; Turner K; Picton S; Barbaro PM; Poulin A; Tam IS; El Demellawy D; Empringham B; Whitlock JA; Raghunathan A; Swanson AA; Suchi M; Brandt JM; Yaseen NR; Weinstein JL; Eldem I; Sisk BA; Sridhar V; Atkinson M; Massoth LR; Hornick JL; Alexandrescu S; Yeo KK; Petrova-Drus K; Peeke SZ; Muñoz-Arcos LS; Leino DG; Grier DD; Lorsbach R; Roy S; Kumar AR; Garg S; Tiwari N; Schafernak KT; Henry MM; van Halteren AGS; Abla O; Diamond EL; Emile JF
    Blood; 2022 Jan; 139(2):256-280. PubMed ID: 34727172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.
    Bai Y; Sun W; Niu D; Yang X; Diao X; Yu Y; Lin D
    Virchows Arch; 2021 Dec; 479(6):1079-1083. PubMed ID: 33825946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.
    Syrykh C; Ysebaert L; Péricart S; Evrard SM; Meggetto F; Kanoun S; Brousset P; Laurent C
    Virchows Arch; 2021 Apr; 478(4):779-783. PubMed ID: 33011863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.
    Bhatia A; Hatzoglou V; Ulaner G; Rampal R; Hyman DM; Abdel-Wahab O; Durham BH; Dogan A; Ozkaya N; Yabe M; Petrova-Drus K; Panageas KS; Reiner A; Rosenblum M; Diamond EL
    Neuro Oncol; 2020 Jul; 22(7):979-992. PubMed ID: 31950179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcifying nested stromal-epithelial tumor: a clinicopathologic and molecular genetic study of eight cases highlighting metastatic potential and recurrent CTNNB1 and TERT promoter alterations.
    Papke DJ; Dong F; Zhang X; Kozielski R; Basturk O; Fletcher CDM; Zhao L
    Mod Pathol; 2021 Sep; 34(9):1696-1703. PubMed ID: 33994539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Series and Review.
    Adnan A; Powell PR; Staples CJ; Evanson B; Parekh PK
    Am J Dermatopathol; 2021 May; ():. PubMed ID: 33989217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by
    Razanamahery J; Diamond EL; Cohen-Aubart F; Plate KH; Lourida G; Charlotte F; Hélias-Rodzewicz Z; Goyal G; Go RS; Dogan A; Abdel-Wahab O; Durham B; Ozkaya N; Amoura Z; Emile JF; Haroche J
    Haematologica; 2020 Jan; 105(1):e5-e8. PubMed ID: 31123032
    [No Abstract]   [Full Text] [Related]  

  • 39. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
    Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
    Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALK-rearranged histiocytosis: Report of two cases with involvement of the central nervous system.
    Rossi S; Gessi M; Barresi S; Tamburrini G; Giovannoni I; Ruggiero A; Colafati GS; Frassanito P; Carboni A; Alexandre A; Cacchione A; Trombatore P; Diomedi-Camassei F; Gaspari S; Gianno F; Marras CE; Cecinati V; Carai A; Mastronuzzi A; Alaggio R
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):878-881. PubMed ID: 34048085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.